How Therapy Disciplines Contribute to Medication Safety in a Population Where the Average Patient Takes Multiple Prescriptions Daily

Polypharmacy — commonly defined as the concurrent use of five or more medications, though the clinically significant threshold varies by patient — is close to a universal characteristic of the home health patient population rather than an exceptional circumstance, and it carries independent clinical risk that exists apart from and in addition to the risks of any single medication in the regimen. Drug-drug interactions, cumulative anticholinergic and sedative burden, and the simple functional demands of managing a complex medication schedule all scale with the number of medications a patient takes, and the home health interdisciplinary team’s role in identifying and addressing polypharmacy risk is a clinical contribution that extends beyond the medication reconciliation that nursing performs at start of care.

Physical therapy’s contribution to polypharmacy risk identification centers on the fall risk and balance implications of medication classes with known central nervous system and cardiovascular effects. Benzodiazepines, sedative-hypnotics, anticholinergic medications, and antihypertensive medications with orthostatic hypotension risk each carry documented fall risk that compounds when multiple such medications are present in a single patient’s regimen. The PT who observes balance impairment, gait instability, or orthostatic symptoms during a therapy session and who connects these clinical observations to the patient’s medication list — rather than attributing them solely to the primary diagnosis or general deconditioning — is providing polypharmacy risk identification that directly informs the medication review the prescribing physician or pharmacist should conduct.

Occupational therapy’s medication management assessment addresses the functional demands of polypharmacy — the fine motor dexterity to open medication containers and handle small pills, the visual capacity to read medication labels and distinguish similar-appearing pills, the cognitive capacity to organize and track a complex multi-medication schedule with different dosing frequencies and administration requirements, and the health literacy to understand what each medication is for and why adherence matters. The OT assessment that identifies the specific functional barrier compromising a patient’s medication management — rather than generically recommending ‘improve medication adherence’ — produces intervention that is directly actionable: pill organizers matched to the patient’s cognitive and dexterity capacity, medication administration timing aligned with the patient’s actual daily routine, and the caregiver involvement structure appropriate to the patient’s specific functional limitations.

Cognitive impairment and polypharmacy interact in ways that create a specific clinical risk pattern that home health therapy is positioned to identify. The patient with mild cognitive impairment who cannot reliably track whether they have taken a medication dose is at risk for both missed doses and duplicate doses, each carrying distinct safety implications. The anticholinergic burden of many common medications — including some antihistamines, certain bladder medications, and some psychiatric medications — independently worsens cognitive function in ways that can be mistaken for disease progression rather than recognized as a medication effect. OT and SLP cognitive assessment that identifies cognitive impairment potentially attributable to medication effects, communicated clearly to the prescribing team, can prompt a medication review that improves cognitive function through deprescribing rather than accepting apparent cognitive decline as an unmodifiable disease trajectory.

Medical social work’s contribution to polypharmacy addresses the access, cost, and health system fragmentation factors that frequently drive polypharmacy risk independent of clinical necessity. The patient who is prescribed medications by multiple specialists who do not communicate with each other, the patient who continues taking a medication a previous prescriber discontinued because no one clearly communicated the discontinuation, and the patient whose medication non-adherence reflects cost barriers that produce inconsistent dosing rather than clinical instability requiring dose adjustment each present a polypharmacy risk pattern that MSW care coordination and pharmacy assistance program navigation specifically addresses.

Deprescribing — the systematic, physician-led process of identifying and discontinuing medications whose risks outweigh their benefits for a specific patient — is a clinical process that the home health interdisciplinary team supports through the functional and cognitive observation that informs deprescribing clinical decisions, even though deprescribing decisions themselves remain a physician and pharmacist responsibility. The home health team that documents specific functional observations — this patient’s gait became notably safer after their benzodiazepine was reduced, this patient’s cognitive clarity improved after an anticholinergic medication was discontinued — provides the clinical evidence that supports and reinforces deprescribing decisions and that helps prescribers evaluate whether a deprescribing trial produced the anticipated functional benefit.

Communication with the prescribing physician and pharmacist is the clinical action that converts therapy discipline medication observations into actual medication changes, and home health agencies with strong physician and pharmacy communication practices — clear, specific, and timely reporting of medication-related clinical observations — produce more medication safety impact from their interdisciplinary polypharmacy awareness than agencies where these observations remain in visit notes without direct clinical communication to the prescribing team.

Humane Care Therapy Inc. is therapist-owned and OT-operated — and our clinical leadership understands medication safety as a genuinely interdisciplinary responsibility that extends well beyond nursing medication reconciliation. We provide OT, PT, and MSW staffing with polypharmacy risk awareness for home health agencies across Houston and Southeast Texas. Call (281) 619-3771, email info@humanecaretherapy.com, or visit humanecaretherapy.com.